Abuse Potential of Intravenous Oxycodone/Naloxone Solution in Nondependent Recreational Drug Users
Open Access
- 23 April 2014
- journal article
- research article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 34 (6) , 421-429
Abstract
Abuse of opioid analgesics has become a public health issue. Some opioid abusers use intravenous administration to increase the magnitude of positive reinforcing effects. Intravenous co-administration of oxycodone with naloxone, an opioid antagonist, may reduce these rewarding effects and discourage abuse. A 2:1 oxycodone:naloxone (OXN) tablet formulation has been studied in the USA for the management of moderate-to-severe chronic pain. Intravenous administration of a 2:1 oxycodone:naloxone solution (sOXN) reflects the oxycodone:naloxone ratio found in laboratory studies of OXN following tampering for intravenous administration. The objective of this study was to characterize abuse-deterrent properties of sOXN.Keywords
This publication has 16 references indexed in Scilit:
- Strategies to Reduce the Tampering and Subsequent Abuse of Long-acting Opioids: Potential Risks and Benefits of Formulations With Physical or Pharmacologic Deterrents to TamperingMayo Clinic Proceedings, 2012
- Abuse risks and routes of administration of different prescription opioid compounds and formulationsHarm Reduction Journal, 2011
- Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine‐maintained intravenous heroin abusersAddiction, 2010
- Can abuse deterrent formulations make a difference? Expectation and speculationHarm Reduction Journal, 2009
- A randomised controlled trial with prolonged‐release oral oxycodone and naloxone to prevent and reverse opioid‐induced constipationEuropean journal of pain, 2009
- The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusersDrug and Alcohol Dependence, 2008
- Population Pharmacokinetics of Intravenous, Intramuscular, and Intranasal Naloxone in Human VolunteersTherapeutic Drug Monitoring, 2008
- Validation of the multiple-choice procedure for investigating drug reinforcement in humans.Experimental and Clinical Psychopharmacology, 1996
- Multiple-choice procedureBehavioural Pharmacology, 1993
- Two New Rating Scales for Opiate WithdrawalThe American Journal of Drug and Alcohol Abuse, 1987